These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35004078)

  • 1. CD38 - Negative Anaplastic Plasma Cell Myeloma: A Rare Case Report.
    Thi Vinh Do A; Lan Anh L
    Cureus; 2022 Jan; 14(1):e20909. PubMed ID: 35004078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells.
    Jeong TD; Park CJ; Shim H; Jang S; Chi HS; Yoon DH; Kim DY; Lee JH; Lee JH; Suh C; Lee KH
    Korean J Hematol; 2012 Dec; 47(4):260-6. PubMed ID: 23320004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of cell morphology and immunophenotypic characteristics in 47 cases of multiple myeloma].
    Su XD; Lin R; Xu XL; Chen X; Zhan WL; Zheng JP; Fan CL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):137-41. PubMed ID: 25687061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
    Kim D; Park CY; Medeiros BC; Weissman IL
    Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison and analysis of minimal residual disease in multiple myeloma patients detected by 4-color and 8-color fluorescence antibody panels].
    Wang YZ; Lu J; Hao L; Chang Y; He LL; Huang XJ; Liu YR
    Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):272-278. PubMed ID: 28468086
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular Involvement of a CD138-Negative Anaplastic Myeloma: A Diagnostic Dilemma.
    Choudhuri J; Janmey V; Ding J; Dailey D; Shi Y; Wang Y
    Hematol Rep; 2023 Jan; 15(1):66-72. PubMed ID: 36810550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of multiple myeloma cells using multicolor immunofluorescence and flow cytometry].
    Tousková M; Maisnar V; Krejsek J; Kopecký O
    Vnitr Lek; 1999 Dec; 45(12):708-12. PubMed ID: 10951845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.
    Lin P; Owens R; Tricot G; Wilson CS
    Am J Clin Pathol; 2004 Apr; 121(4):482-8. PubMed ID: 15080299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic transformation in plasma cell dyscrasia.
    Cruse JM; Lewis RE; Webb RN; Sanders CM; Tillman BF; Beason K; Lam J; Koehler J
    Exp Mol Pathol; 2006 Oct; 81(2):157-61. PubMed ID: 16908019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cell leukemia: a retrospective study of 10 cases.
    Agarwal AD; Brahmbhatt BS; Parikh BP; Shah MJ
    Indian J Cancer; 2014; 51(1):18-9. PubMed ID: 24947090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of CD19 positive cell counts in bone marrow with therapeutic efficacy in patients with multiple myeloma].
    Zhang L; Zhou ZH; Li XY; Ouyang J; Su C; Li J; Luo SK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):64-7. PubMed ID: 21362223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
    Kara IO; Duman BB; Afsar CU
    J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic analysis of abnormal plasma cell clones in bone marrow of primary systemic light chain amyloidosis patients.
    Hu Y; Wang M; Chen Y; Chen X; Fang F; Liu S; Zhang Y; Wu X; Zhu P
    Chin Med J (Engl); 2014; 127(15):2765-70. PubMed ID: 25146610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple myeloma with CD138 changed from positive to negative: A case report.
    Yu J; Tan L; Wu Q; Rao Y; Ao J; Yang W; Zou B; Chen J
    Cytometry B Clin Cytom; 2021 Mar; 100(2):249-253. PubMed ID: 31967404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Bone Marrow Flow Cytometry Analysis in Patients With Plasma Cell Neoplasm in Thailand: A Single Institutional Study.
    Limvorapitak W; Srisum-Ang T; Chimres C; Warnnissorn N; Kanitsap N
    Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):e27-37. PubMed ID: 26796980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunophenotype characteristics in multiple myeloma cells and their significance].
    Sun Y; Fang MY; Liu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):381-4. PubMed ID: 20416173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
    Flores-Montero J; de Tute R; Paiva B; Perez JJ; Böttcher S; Wind H; Sanoja L; Puig N; Lecrevisse Q; Vidriales MB; van Dongen JJ; Orfao A
    Cytometry B Clin Cytom; 2016 Jan; 90(1):61-72. PubMed ID: 26100534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
    Sorigue M; Juncà J; Gassiot S; Millá F; Mate JL; Navarro JT
    Cytometry B Clin Cytom; 2014 Mar; ():. PubMed ID: 24659135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of CD138/syndecan-1 for multiple myeloma immunophenotypes].
    Zhuang JL; Wang X; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1023-7. PubMed ID: 16403272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.